Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncolytic vaccinia virus for the treatment of cancer.
Guse K, Cerullo V, Hemminki A. Guse K, et al. Among authors: hemminki a. Expert Opin Biol Ther. 2011 May;11(5):595-608. doi: 10.1517/14712598.2011.558838. Epub 2011 Feb 22. Expert Opin Biol Ther. 2011. PMID: 21338330 Review.
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells.
Bauerschmitz GJ, Guse K, Kanerva A, Menzel A, Herrmann I, Desmond RA, Yamamoto M, Nettelbeck DM, Hakkarainen T, Dall P, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Among authors: hemminki a. Mol Ther. 2006 Aug;14(2):164-74. doi: 10.1016/j.ymthe.2006.01.010. Epub 2006 Mar 31. Mol Ther. 2006. PMID: 16580264 Free article.
Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
Guse K, Dias JD, Bauerschmitz GJ, Hakkarainen T, Aavik E, Ranki T, Pisto T, Särkioja M, Desmond RA, Kanerva A, Hemminki A. Guse K, et al. Among authors: hemminki a. Gene Ther. 2007 Jun;14(11):902-11. doi: 10.1038/sj.gt.3302949. Epub 2007 Mar 22. Gene Ther. 2007. PMID: 17377596
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.
Eriksson M, Guse K, Bauerschmitz G, Virkkunen P, Tarkkanen M, Tanner M, Hakkarainen T, Kanerva A, Desmond RA, Pesonen S, Hemminki A. Eriksson M, et al. Among authors: hemminki a. Mol Ther. 2007 Dec;15(12):2088-93. doi: 10.1038/sj.mt.6300300. Epub 2007 Sep 11. Mol Ther. 2007. PMID: 17848962 Free article.
Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.
Rajecki M, af Hällström T, Hakkarainen T, Nokisalmi P, Hautaniemi S, Nieminen AI, Tenhunen M, Rantanen V, Desmond RA, Chen DT, Guse K, Stenman UH, Gargini R, Kapanen M, Klefström J, Kanerva A, Pesonen S, Ahtiainen L, Hemminki A. Rajecki M, et al. Among authors: hemminki a. Int J Cancer. 2009 Nov 15;125(10):2441-9. doi: 10.1002/ijc.24608. Int J Cancer. 2009. PMID: 19672857 Free article.
Oncolytic adenovirus treatment of a patient with refractory neuroblastoma.
Pesonen S, Helin H, Nokisalmi P, Escutenaire S, Ribacka C, Sarkioja M, Cerullo V, Guse K, Bauerschmitz G, Laasonen L, Kantola T, Ristimaki A, Rajecki M, Oksanen M, Haavisto E, Kanerva A, Joensuu T, Hemminki A. Pesonen S, et al. Among authors: hemminki a. Acta Oncol. 2010;49(1):117-9. doi: 10.3109/02841860903071369. Acta Oncol. 2010. PMID: 19735000 No abstract available.
341 results